CJC-1295 with Ipamorelin
CJC-1295 is a man-made analog of the growth hormone-releasing hormone (GHRH) that utilizes the drug affinity complex (DAC) technology and provides an enhanced biological half-life. Extensively studied in research related to the GHRH axis and pituitary gland.
About CJC-1295
CJC-1295 is a variant of GHRH(1-29) using Drug Affinity Complex (DAC) technology to allow binding with serum albumin, resulting in an extended half-life relative to normal GHRH. The feature makes it particularly applicable for the purpose of conducting prolonged studies involving the GHRH axis.
The drug has been used in studies relating to GH pulsatility, investigation into the IGF-1 axis, and studies regarding somatotropic function over prolonged periods of time.
Research Areas
- Extended GHRH receptor activation and sustained GH release research
- IGF-1 axis stimulation and anabolic pathway investigation
- Pituitary somatotroph function studies in animal models
- Bone density and lean mass research in controlled environments
- Drug affinity complex (DAC) pharmacokinetic research
- Combined GHRH/GHSR pathway modulation studies
⚠ Research Use Only.
All products supplied by PeptidesX are intended strictly for in-vitro laboratory and scientific research. Not for human consumption, medical use, veterinary use, or therapeutic application. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.
Identity & Purity
HPLC / MS-UPLC| Test | Specification | Result |
| Appearance | White lyophilised powder | ✓ Conforms |
| HPLC Purity | ≥ 98.0% | 99.1% ✓ |
| MS Molecular Weight | Expected ± 0.5 Da | Confirmed ✓ |
| Amino Acid Analysis | Theoretical sequence | Confirmed ✓ |
| Water Content (KF) | ≤ 8.0% | 5.4% ✓ |
| Net Peptide Content | ≥ 85.0% | 90.8% ✓ |
Safety Testing
Endotoxin / Metals| Test | Specification | Result |
| Endotoxin (LAL) | ≤ 5 EU/mg | 0.9 EU/mg ✓ |
| Bioburden | ≤ 100 CFU/g | <10 CFU/g ✓ |
| Lead (Pb) | ≤ 10 ppm | <0.1 ppm ✓ |
| Arsenic (As) | ≤ 5 ppm | <0.1 ppm ✓ |
| Mercury (Hg) | ≤ 3 ppm | <0.1 ppm ✓ |
| Cadmium (Cd) | ≤ 5 ppm | <0.1 ppm ✓ |
Solubility: Water. Mix gently by rolling — do not vortex.
Returns: Sealed, unopened vials may be returned within 14 days of receipt. Opened vials cannot be returned.
CJC-1295 with Ipamorelin is a peptide combination commonly studied for its effects on growth hormone signalling pathways. Researchers frequently investigate this blend because the two peptides work through complementary mechanisms involved in natural growth hormone release.
The combination is popular in research because CJC-1295 and Ipamorelin target different aspects of growth hormone regulation. Scientists study whether using both peptides together may produce different effects compared to investigating either peptide individually.
CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue designed to stimulate growth hormone signalling pathways. It is one of the most widely researched peptides in growth hormone-related studies.
Ipamorelin is a selective growth hormone secretagogue that acts through ghrelin receptor pathways. Researchers study its potential role in growth hormone release, recovery processes, and metabolic function.
Researchers believe the combination works through complementary pathways. CJC-1295 acts on growth hormone-releasing hormone receptors, while Ipamorelin interacts with ghrelin receptors. Together, they are studied for their influence on growth hormone signalling and related biological processes.
Current research areas include:
. Growth hormone signalling studies
. Recovery and regeneration research
. Lean body composition investigations
. Muscle biology research
. Healthy ageing studies
. Exercise recovery research
. Metabolic function studies
. Sleep quality research
Researchers continue to investigate how this peptide combination influences growth hormone pathways and downstream biological processes. It remains one of the most studied peptide blends within growth hormone research.
Yes. Recovery-related research is among the most common scientific applications of this peptide combination. Researchers investigate its relationship with tissue repair, exercise recovery, and regenerative processes.
Body composition research is another major area of interest. Scientists continue to study how growth hormone-related pathways may influence muscle tissue, fat metabolism, and metabolic health.
Research-grade CJC-1295 with Ipamorelin is available through specialist peptide suppliers serving the UK research community. Availability may vary depending on supplier inventory and batch production schedules.
Researchers should purchase CJC-1295 with Ipamorelin from reputable suppliers that provide batch-specific Certificates of Analysis, purity testing results, and transparent quality assurance procedures.
Yes. Research-grade CJC-1295 with Ipamorelin may be available from selected peptide suppliers online. Researchers should review analytical testing, purity data, and supplier reputation before purchasing.
This peptide blend is commonly supplied as a lyophilised powder in various vial strengths. Available concentrations may vary depending on supplier offerings and research requirements.
Premium research-grade peptide blends are typically verified through HPLC and mass spectrometry testing. Batch-specific purity information is generally available through a Certificate of Analysis.
CJC-1295 with Ipamorelin is commonly supplied as a lyophilised peptide powder and is reconstituted using appropriate laboratory-grade diluents. Researchers should follow established laboratory protocols and handling procedures.
Lyophilised peptide blends should be stored according to the supplier's recommendations. Proper storage conditions help maintain peptide stability and research integrity.
Yes. A batch-specific Certificate of Analysis provides important information regarding peptide identity, purity, and analytical testing performed during quality control.
Researchers should look for:
. Batch-specific Certificates of Analysis
. HPLC purity verification
. Mass spectrometry testing
. Transparent quality control standards
. Reliable UK shipping
. Consistent stock availability
CJC-1295 with Ipamorelin remains one of the most recognised peptide combinations because it combines two extensively studied growth hormone-related peptides into a single research product. Its broad research profile continues to attract significant scientific interest worldwide.